Comparative Trial to Investigate the Efficacy and Safety of Desmopressin for the Treatment of Nocturia in Adult Women

PHASE2CompletedINTERVENTIONAL
Enrollment

178

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Nocturia
Interventions
DRUG

A. Desmopressin 10 microgram

1 orally disintegrating tablet every night during study period

DRUG

B: Desmopressin 25 microgram

1 orally disintegrating tablet every night during study period

DRUG

C: Placebo

1 orally disintegrating tablet every night during study period

Trial Locations (36)

Unknown

Japanese Red Cross Nagoya Daiichi Hospital, Aichi

Clinic Tsudanuma, Chiba

University of Fukui Hospital, Fukui

Kato Clinic, Gunma

Umeyama Clinic, Gunma

Harada Urology Clinic, Hyōgo

Sakaguchi Urological Clinic, Hyōgo

Nakamura Urology Clinic, Kanagawa

Nishi-Yokohama International Hospital, Kanagawa

Yokohama Shinmidori General Hospital, Kanagawa

Izumino Hospital, Bouchikai, Kochi

Kamei Clinic, Kochi

Den Urology Clinic, Osaka

Iwasa Clinic, Osaka

Kanno Clinic, Osaka

Morimoto Clinic, Osaka

Naka Clinic, Osaka

Uemura Clinic, Osaka

Urology department Kuroda Clinic, Osaka

Yamaguchi Clinic, Osaka

Yamanaka Clinic, Osaka

Fukuda Clinic, Saitama

Yasuda Urology Clinic, Saitama

Hirano Clinic, Tokyo

Hirata Internal Medicine Urology Clinic, Tokyo

J Tower Clinic, Tokyo

Koganeibashi Sakura Clinic, Tokyo

Kunitachi Sakura Hospital, Tokyo

Kusunoki Clinic, Tokyo

Moriguchi Clinic, Tokyo

Nakanoma Clinic Urology Department, Tokyo

Ogawa Clinic, Tokyo

Ogikubo Ekimae Clinic, Tokyo

Shibuya Shin-minamiguchi Clinic, Tokyo

Tokyo Kamata Hospital, Tokyo

Toru Clinic, Tokyo

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY